Tagged With EpiPen

Ten years ago, I testified before Congress about drug pricing — and it's only gotten worse. Here's what's wrong, and how we may be able to fix it.


Mylan tumbles on reported shortages of its life-saving EpiPens


Dispensed: Complaints of broken EpiPens, what pharma thinks of Amazon, and research-less unicorns



People rely on the EpiPen in life-or-death situations, but the devices are remarkably hard to test. Here’s why.


EpiPens weren’t working. It took 3 years and the FDA stepping in before serious change — with potentially deadly outcomes


Drug giant Novartis is gearing up to release a cheaper EpiPen rival, but one big factor may make competition tricky



Mylan stock dropped 7% after second quarter sales slumped


There's a shortage of EpiPens in the US


Advisers are telling investors to go scorched earth on the company that makes EpiPen


It sounds like the maker of EpiPen is freaking out ahead of a big shareholder meeting


The chairman of the company behind the EpiPen reportedly flipped everyone off when they asked about drug pricing


The chairman of the company behind the EpiPen made $98 million in 2016



Mylan is recalling EpiPens in the US


The EpiPen just got some more competition -- but there's a catch


The EpiPen maker's CEO totally backs Trump on drug prices -- except for how he plans to lower them


The $300 generic EpiPen is here



Mylan says it won't testify at a Senate hearing about the EpiPen


Mylan and the DOJ can't seem to get on the same page these days


Investigations are piling up at Mylan


Outrage over the price of the EpiPen actually led to more prescriptions for the device